Engineered Probiotic for the Inhibition of Salmonella via Tetrathionate-Induced Production of Microcin H47
Open accessThe DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Abstract
Complications arising from antibiotic-resistant bacteria are becoming one of the key issues in modern medicine. Members of drug-resistant Enterobacteriaceae spp. include opportunistic pathogens (e.g., Salmonella spp.) that are among the leading causes of morbidity and mortality worldwide. Overgrowth of these bacteria is considered a hallmark of intestinal dysbiosis. Microcins (small antimicrobial peptides) produced by some gut commensals can potentially cure these conditions by inhibiting these pathogens and have been proposed as a viable alternative to antibiotic treatment. In this proof-of-concept work, we leverage this idea to develop a genetically engineered prototype probiotic to inhibit Salmonella spp. upon exposure to tetrathionate, a molecule produced in the inflamed gut during the course of Salmonella infection. We developed a plasmid-based system capable of conferring the ability to detect and utilize tetrathionate, while at the same time producing microcin H47. We transferred this plasmid-based system to Escherichia coli and demonstrated the ability of the engineered strain to inhibit growth of Salmonella in anaerobic conditions while in the presence of tetrathionate, with no detectable inhibition in the absence of tetrathionate. In direct competition assays between the engineered E. coli and Salmonella, the engineered E. coli had a considerable increase in fitness advantage in the presence of 1 mM tetrathionate as compared to the absence of tetrathionate. In this work, we have demonstrated the ability to engineer a strain of E. coli capable of using an environmental signal indicative of intestinal inflammation as an inducing molecule, resulting in production of a microcin capable of inhibiting the organism responsible for the inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, coupling gene expression to biosensors of reactive oxygen and nitrogen species for the treatment of inflammatory bowel disease may help deliver effectors specifically where activity is beneficial7,28.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other groups have reported the successful production of antimicrobial peptides from EcN that are effective for significantly decreasing murine colonization by Enterococcal species36 or Salmonella typhimurium28.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [28]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enzymatic assembly of DNA molecules up to several hundred kilobases
Gibson, D. G., Young, L., Chuang, R.-Y., Venter, J. C., Hutchison, C. A., & Smith, H. O. (2009) · Nature Methods · doi:10.1038/nmeth.1318 · Cited by 9,996
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Bacteriocins—A viable alternative to antibiotics?
Cotter, P. D., Ross, R. P., & Hill, C. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2937 · Cited by 1,793
Lenski, R. E., Rose, M. R., Simpson, S. C., & Tadler, S. C. (1991) · The American Naturalist · doi:10.1086/285289 · Cited by 1,580
Gut inflammation provides a respiratory electron acceptor for Salmonella
Winter, S. E., Thiennimitr, P., Winter, M. G., Butler, B. P., Huseby, D. L., Crawford, R. W., Russell, J. M., Bevins, C. L., Adams, L. G., Tsolis, R. M., et al. (2010) · Nature · doi:10.1038/nature09415 · Cited by 1,290
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
Ng, K. M., Ferreyra, J. A., Higginbottom, S. K., Lynch, J. B., Kashyap, P. C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B. C., Monack, D. M., et al. (2013) · Nature · doi:10.1038/nature12503 · Cited by 1,035
Host-Derived Nitrate Boosts Growth of E. coli in the Inflamed Gut
Winter, S. E., Winter, M. G., Xavier, M. N., Thiennimitr, P., Poon, V., Keestra, A. M., Laughlin, R. C., Gomez, G., Wu, J., Lawhon, S. D., et al. (2013) · Science · doi:10.1126/science.1232467 · Cited by 1,019
Microcins mediate competition among Enterobacteriaceae in the inflamed gut
Sassone-Corsi, M., Nuccio, S.-P., Liu, H., Hernandez, D., Vu, C. T., Takahashi, A. A., Edwards, R. A., & Raffatellu, M. (2016) · Nature · doi:10.1038/nature20557 · Cited by 549
Hwang, I. Y., Koh, E., Wong, A., March, J. C., Bentley, W. E., Lee, Y. S., & Chang, M. W. (2017) · Nature Communications · doi:10.1038/ncomms15028 · Cited by 472
Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation
Riglar, D. T., Giessen, T. W., Baym, M., Kerns, S. J., Niederhuber, M. J., Bronson, R. T., Kotula, J. W., Gerber, G. K., Way, J. C., & Silver, P. A. (2017) · Nature Biotechnology · doi:10.1038/nbt.3879 · Cited by 426
Cited by
Isabella, V. M., Ha, B. N., Castillo, M. J., Lubkowicz, D. J., Rowe, S. E., Millet, Y. A., Anderson, C. L., Li, N., Fisher, A. B., West, K. A., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4222 · Cited by 605
Developing a new class of engineered live bacterial therapeutics to treat human diseases
Charbonneau, M. R., Isabella, V. M., Li, N., & Kurtz, C. B. (2020) · Nature Communications · doi:10.1038/s41467-020-15508-1 · Cited by 523
Antibiotic perturbations to the gut microbiome
Fishbein, S. R. S., Mahmud, B., & Dantas, G. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00933-y · Cited by 440
Bacterial antagonism in host-associated microbial communities
García-Bayona, L., & Comstock, L. E. (2018) · Science · doi:10.1126/science.aat2456 · Cited by 373
Cao, Z., Wang, X., Pang, Y., Cheng, S., & Liu, J. (2019) · Nature Communications · doi:10.1038/s41467-019-13727-9 · Cited by 337
Genetically stable CRISPR-based kill switches for engineered microbes
Rottinghaus, A. G., Ferreiro, A., Fishbein, S. R. S., Dantas, G., & Moon, T. S. (2022) · Nature Communications · doi:10.1038/s41467-022-28163-5 · Cited by 278
Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
Lynch, J. P., Goers, L., & Lesser, C. F. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.02.002 · Cited by 230
Microbiome therapeutics: exploring the present scenario and challenges
Yadav, M., & Chauhan, N. S. (2021) · Gastroenterology report · doi:10.1093/gastro/goab046 · Cited by 181
Engineering probiotics for therapeutic applications: recent examples and translational outlook
Aggarwal, N., Breedon, A. M. E., Davis, C. M., Hwang, I. Y., & Chang, M. W. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.02.016 · Cited by 154
Engineering probiotics as living diagnostics and therapeutics for improving human health
Zhou, Z., Chen, X., Sheng, H., Shen, X., Sun, X., Yan, Y., Wang, J., & Yuan, Q. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-01318-z · Cited by 145
Next generation probiotics: Engineering live biotherapeutics
Murali, S. K., & Mansell, T. J. (2024) · Biotechnology Advances · doi:10.1016/j.biotechadv.2024.108336 · Cited by 153
Adaptive Strategies of the Candidate Probiotic E. coli Nissle in the Mammalian Gut
Crook, N., Ferreiro, A. L., Gasparrini, A. J., Pesesky, M. W., Gibson, M. K., Wang, B., Sun, X., Condiotte, Z. J., Dobrowolski, S., Peterson, D. A., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.02.005 · Cited by 137
Leonard, S. P., Perutka, J., Powell, J. E., Geng, P., Richhart, D. D., Byrom, M., Kar, S., Davies, B. W., Ellington, A. D., Moran, N. A., et al. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00399 · Cited by 129
Intestinal Delivery of Probiotics: Materials, Strategies, and Applications
Li, C., Wang, Z., Xiao, H., & Wu, F. (2024) · Advanced Materials · doi:10.1002/adma.202310174 · Cited by 117
Engineered Probiotics for Detection and Treatment of Inflammatory Intestinal Diseases
Barra, M., Danino, T., & Garrido, D. A. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00265 · Cited by 108
Bacteria and bacterial derivatives as delivery carriers for immunotherapy
Kang, S., Nguyen, D.-H., Yoo, S. W., & Min, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114085 · Cited by 106
Luo, H., Wu, F. Q., Wang, X., Lin, S., Zhang, M., Cao, Z., & Liu, J. (2023) · Materials Today · doi:10.1016/j.mattod.2023.01.001 · Cited by 105
Bacteriocins to Thwart Bacterial Resistance in Gram Negative Bacteria
Telhig, S., Said, L. B., Zirah, S., Fliss, I., & Rebuffat, S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.586433 · Cited by 107
Enlisting commensal microbes to resist antibiotic-resistant pathogens
Keith, J. W., & Pamer, E. G. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180399 · Cited by 87
Choi, G. H., Holzapfel, W. H., & Todorov, S. D. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2090227 · Cited by 96
Singh, R. P., Shadan, A., & Ma, Y. (2022) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-09992-8 · Cited by 75
Nougayrède, J.-P., Chagneau, C. V., Motta, J.-P., Bossuet-Greif, N., Belloy, M., Taieb, F., Gratadoux, J.-J., Thomas, M., Langella, P., & Oswald, E. (2021) · mSphere · doi:10.1128/msphere.00624-21 · Cited by 82
“enzyme against Pseudomonas aeruginosa (43) or a microcin induced upon sensing of Salmonella infection (44).”
BackgroundMethodBacteria-Induced Colloidal Encapsulation for Probiotic Oral Delivery
Zhang, C., Gao, X., Ren, X., Xu, T., Peng, Q., Zhang, Y., Chao, Z., Jiang, W., Jia, L., & Han, L. (2023) · ACS Nano · doi:10.1021/acsnano.3c00600 · Cited by 79
Engineered Bacteria-Based Living Materials for Biotherapeutic Applications
Omer, R., Mohsin, M. Z., Mohsin, A., Mushtaq, B. S., Huang, X., Guo, M., Zhuang, Y., & Huang, J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.870675 · Cited by 77
Engineered microbial systems for advanced drug delivery
Shen, H., Aggarwal, N., Wun, K. S., Lee, Y. S., Hwang, I. Y., & Chang, M. W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114364 · Cited by 76
Targeted Therapeutic Strategies in the Battle Against Pathogenic Bacteria
Yang, B., Fang, D., Lv, Q., Wang, Z., & Liu, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.673239 · Cited by 85
Shamoon, M., Martin, N. M., & O'Brien, C. L. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104344 · Cited by 78
Hartwig, O., Boushehri, M. A. S., Shalaby, K. S., Loretz, B., Lamprecht, A., & Lehr, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113828 · Cited by 74
Zuo, F., Chen, S., & Marcotte, H. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107654 · Cited by 73
Advanced delivery systems for peptide antibiotics
Cesaro, A., Lin, S., Pardi, N., & de la Fuente‐Núñez, C. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114733 · Cited by 75
Genetic Engineering of Resident Bacteria in the Gut Microbiome
Arnold, J. H., Glazier, J., & Mimee, M. (2023) · Journal of Bacteriology · doi:10.1128/jb.00127-23 · Cited by 67
Biosensing in Smart Engineered Probiotics
Rottinghaus, A. G., Amrofell, M. B., & Moon, T. S. (2020) · Biotechnology Journal · doi:10.1002/biot.201900319 · Cited by 66
Probiotic engineering strategies for the heterologous production of antimicrobial peptides
Mejía-Pitta, A., Broset, E., & de la Fuente‐Núñez, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113863 · Cited by 58
Engineered bacteria as drug delivery vehicles: Principles and prospects
Zhou, Y., & Han, Y. C. (2022) · Engineering Microbiology · doi:10.1016/j.engmic.2022.100034 · Cited by 56
Microcins reveal natural mechanisms of bacterial manipulation to inform therapeutic development
Parker, J. K., & Davies, B. W. (2022) · Microbiology · doi:10.1099/mic.0.001175 · Cited by 55
Mortzfeld, B. M., Palmer, J. D., Bhattarai, S. K., Dupre, H. L., Mercado–Lubo, R., Silby, M. W., Bang, C., McCormick, B. A., & Bucci, V. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2127633 · Cited by 53
Self-citationDas, A., Behera, R. N., Kapoor, A., & Ambatipudi, K. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c03834 · Cited by 41
Engineering a genome‐reduced bacterium to eliminate Staphylococcus aureus biofilms in vivo
Garrido, V., Piñero‐Lambea, C., Rodríguez-Arce, I., Paetzold, B., Ferrar, T. S., Weber, M. L., García-Ramallo, E., Gallo, C., Collantes, M., Peñuelas, I., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202010145 · Cited by 49
From microbiome composition to functional engineering, one step at a time
Burz, S. D., Čaušević, S., Co, A. D., Dmitrijeva, M., Engel, P., Garrido‐Sanz, D., Greub, G., Hapfelmeier, S., Hardt, W., Hatzimanikatis, V., et al. (2023) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00063-23 · Cited by 53
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases
Meng, J., Liu, S., & Wu, X. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2023.2190392 · Cited by 49
Targeting the human gut microbiome with small-molecule inhibitors
Woo, A. Y. M., Aguilar Ramos, M. A., Narayan, R., Richards-Corke, K. C., Wang, M. L., Sandoval-Espinola, W. J., & Balskus, E. P. (2023) · Nature Reviews Chemistry · doi:10.1038/s41570-023-00471-4 · Cited by 42
Palmer, J. D., Mortzfeld, B. M., Piattelli, E., Silby, M. W., McCormick, B. A., & Bucci, V. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00302 · Cited by 42
Self-citationDiscovery and Bioactivity of the Novel Lasso Peptide Microcin Y
Li, Y., Han, Y., Zeng, Z., Li, W., Feng, S., & Cao, W. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02659 · Cited by 41
Carolak, E., Czajkowska, J., Stypułkowska, A., Waszczuk, W., Dutkiewicz, A., & Grzymajło, K. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2519696 · Cited by 41
Phage lysins for intestinal microbiome modulation: current challenges and enabling techniques
Pottie, I., Vázquez, R., de Wiele, T. V., & Briers, Y. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2387144 · Cited by 38
Genetically engineered bacteria as inflammatory bowel disease therapeutics
Zou, Z., Zhang, X.-P., Zhang, Q., Yin, B., Zhou, Y. Q., & Ye, B. (2024) · Engineering Microbiology · doi:10.1016/j.engmic.2024.100167 · Cited by 38
Synthetic Biology-Driven Microbial Therapeutics for Disease Treatment
Kim, T. H., Cho, B., & Lee, D. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2407.07004 · Cited by 34
Sahoo, D., Rodriguez, E., Nguyen, K. T., & Chintapula, U. K. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00959 · Cited by 32
Understanding and Engineering Distributed Biochemical Pathways in Microbial Communities
Cao, X., Hamilton, J. J., & Venturelli, O. S. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b01006 · Cited by 36
Triassi, A. J., Fields, B. D., Monahan, C. E., Means, J., Park, Y., Doosthosseini, H., Padmakumar, J. P., Isabella, V. M., & Voigt, C. A. (2023) · Cell Systems · doi:10.1016/j.cels.2023.05.004 · Cited by 32
Next-generation probiotics and engineered BEVs for precision therapeutics in osteoporosis
Wei, J., Ding, W., Song, K., Zhang, Y., Luo, Q., & Qi, C. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1581971 · Cited by 31
Living Therapeutics: The Next Frontier of Precision Medicine
Kelly, V. W., Liang, B. K., & Sirk, S. J. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00444 · Cited by 30
Biosensor-based therapy powered by synthetic biology
Wang, C., Zeng, H.-S., Liu, K., Lin, Y.-N., Yang, H., Xie, X., Wei, D., & Ye, J. (2022) · Smart Materials in Medicine · doi:10.1016/j.smaim.2022.10.003 · Cited by 38
Microbiome Therapeutics: A Path Toward Sustainable Healthcare
Kumar, T., & Chauhan, N. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00010-3 · Cited by 30
Acar, S., Bulut, E., Stasiewicz, M. J., & Soyer, Y. (2019) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2019.108275 · Cited by 29
Recent Advances in the Nanoshells Approach for Encapsulation of Single Probiotics
Chen, C., & Zhu, Z. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s419897 · Cited by 27
Engineered Live Biotherapeutics: Progress and Challenges
Tan, Y., Shen, J., Si, T., Ho, C. L., Li, Y., & Dai, L. (2020) · Biotechnology Journal · doi:10.1002/biot.202000155 · Cited by 27
Bosák, J., Hrala, M., Micenková, L., & Šmajs, D. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1816824 · Cited by 26
Zhou, S., Zhao, L., Zuo, W., Zheng, Y., Zhang, P., Sun, Y., Wang, Y., Du, G., & Kang, Z. (2024) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2024.01.006 · Cited by 26
A molecular toolkit for heterologous protein secretion across Bacteroides species
Yeh, Y.-H., Kelly, V. W., Pour, R. R., & Sirk, S. J. (2024) · Nature Communications · doi:10.1038/s41467-024-53845-7 · Cited by 26
New Insights Into DAEC and EAEC Pathogenesis and Phylogeny
Meza-Segura, M., Zaidi, M. B., de León, A. V., Morán-García, N., Martínez‐Romero, E., Nataro, J. P., & Estrada‐García, T. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.572951 · Cited by 28
Synergies of Systems Biology and Synthetic Biology in Human Microbiome Studies
Ezzamouri, B., Shoaie, S., & Ledesma‐Amaro, R. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.681982 · Cited by 26
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. Ø., & Sommer, M. O. A. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-05108-9 · Cited by 29
Engineering microbes for targeted strikes against human pathogens
Hwang, I. Y., Lee, H. L., Huang, J. G., Lim, Y. Y., Yew, W. S., Lee, Y. S., & Chang, M. W. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2827-7 · Cited by 25
Human microbiota peptides: important roles in human health
Shah, A. B., & Shim, S. H. (2025) · Natural Product Reports · doi:10.1039/d4np00042k · Cited by 26
Living Engineered Bacterial Therapeutics: Emerging Affordable Precision Interventions
Srivastava, R., & Lesser, C. F. (2024) · Microbial Biotechnology · doi:10.1111/1751-7915.70057 · Cited by 25
Guan, C., Larson, P. J., Fleming, E. S., Tikhonov, A. P., Mootien, S., Grossman, T. H., Golino, C., & Oh, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276795 · Cited by 24
Synthetic Biology‐Based Engineering Living Therapeutics for Antimicrobial Application
Huang, S., Zhao, S., Zhao, H., Wen, M., & Guo, Z. (2025) · Exploration · doi:10.1002/exp.20240045 · Cited by 26
Hung, Y., Lee, C., Lee, J., Tsai, P.-J., Hsueh, P., & Ko, W. (2021) · Antibiotics · doi:10.3390/antibiotics10091086 · Cited by 22
Daisley, B. A., & Allen‐Vercoe, E. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15237 · Cited by 19
Comparative Genomics and Pan-Genome Driven Prediction of a Reduced Genome of Akkermansia muciniphila
Bukhari, S. A. R., Irfan, M., Ahmad, I., & Chen, L. (2022) · Microorganisms · doi:10.3390/microorganisms10071350 · Cited by 18
Han, Y., Li, Y., Zeng, Z., Li, W., Feng, S., & Cao, W. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01859-22 · Cited by 17
Engineering bacterial theranostics: from logic gates to in vivo applications
Armstrong, A., & Isalan, M. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1437301 · Cited by 18
Combating Infectious Diseases with Synthetic Biology
Khan, A., Ostaku, J., Aras, E., & Şeker, U. Ö. Ş. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00576 · Cited by 17
Toward a systematic design of smart probiotics
Choudhary, R., & Mahadevan, R. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.05.003 · Cited by 17
Zhao, L., Xin, J., Hu, M., Xue, C., & Dong, N. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.10.028 · Cited by 19
Ma, Y., Fu, W., Hong, B., Wang, X., Jiang, S., & Wang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411688 · Cited by 17
Interplay between Regulatory RNAs and Signal Transduction Systems during Bacterial Infection
Piattelli, E., Johann, P., & Soutourina, O. A. (2020) · Genes · doi:10.3390/genes11101209 · Cited by 17
Self-citationLebovich, M., Zeng, M., & Andrews, L. B. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00232 · Cited by 16
Chamas, A., Svensson, C., Maneira, C., Sporniak, M., Figge, M. T., & Lackner, G. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00466 · Cited by 15
Leveraging strain competition to address antimicrobial resistance with microbiota therapies
Steed, D. B., Koundakjian, D., Harris, A. D., Rosato, A. E., Konstantinidis, K. T., & Woodworth, M. H. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2488046 · Cited by 15
Enhancing the antibacterial function of probiotic Escherichia coli Nissle: when less is more
Bartram, E., Asai, M., Gabant, P., & Wigneshweraraj, S. (2023) · Applied and Environmental Microbiology · doi:10.1128/aem.00975-23 · Cited by 13
Yang, F., Yang, F., Huang, J., Yu, H., & Qiao, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137213 · Cited by 13
Novel class IIb microcins show activity against Gram-negative ESKAPE and plant pathogens
Mortzfeld, B. M., Bhattarai, S. K., & Bucci, V. (2024) · eLife · doi:10.7554/elife.102912 · Cited by 12
Self-citationNam, J., Lee, Y., Lee, S., Choi, H., Lee, S. Y., & Yang, D. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108782 · Cited by 14
Riddle, M. S. (2020) · Current Infectious Disease Reports · doi:10.1007/s11908-020-0717-2 · Cited by 11
Allahverdi, M., & Dadmehr, M. (2026) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2026.108917 · Cited by 13
Remotely Controllable Engineered Bacteria for Targeted Therapy of Pseudomonas aeruginosa Infection
Gao, Y., Wei, J., Pu, L., Fu, S., Xing, X., Zhang, R., & Jin, F. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00655 · Cited by 11
Controlling Intestinal Infections and Digestive Disorders Using Probiotics
Kumar, S., Ahmad, M. F., Nath, P., Roy, R., Bhattacharjee, R., Shama, E., Gahatraj, I., Sehrawat, M., Dasriya, V. L., Dhillon, H. S., et al. (2023) · Journal of Medicinal Food · doi:10.1089/jmf.2023.0062 · Cited by 11
Singh, A., Mazumder, A., Das, S., Kanda, A., Tyagi, P. K., & Chaitanya, M. (2024) · Recent Advances in Anti-Infective Drug Discovery · doi:10.2174/0127724344308638240530065552 · Cited by 8
Multilayered safety framework for living diagnostics in the colon
Mecacci, S., Torregrosa-Barragán, L., Asin‐Garcia, E., & Smith, R. W. (2023) · Frontiers in Systems Biology · doi:10.3389/fsysb.2023.1240040 · Cited by 10
Singh, I., Abdulqadir, R. F., Verma, I. K., Awasthi, Y., Ratn, A., Sharma, J., Rawat, M., Dhakad, M. S., Dalal, J., Gupta, Y., et al. (2025) · Food Frontiers · doi:10.1002/fft2.70168 · Cited by 7
Using Probiotics to Mute Salmonella enteric Serovar Typhimurium: An Opinion
Shi, Y., Li, J., Shen, Y., & Sun, Z. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00558 · Cited by 8
Kong, D., Zhang, M., Bhandari, B., Fan, D., & Li, C. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2714682 · Cited by 6
Bacterial Autonomous Intelligent Microrobots for Biomedical Applications
Chen, H., Li, Y., Li, Z., Sun, Y., Gu, W., Chen, C., & Cheng, Y. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70011 · Cited by 6
Ali, R. M., Arshad, H., Zafar, A. Q., Gull, S., Gul, A., Mansoor, F., & Zahid, R. (2025) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.70079 · Cited by 5
Fresh Ideas Bloom in Gut Healthcare to Cross-Fertilize Lake Management
Hellweger, F. L., Vick, C., Rückbeil, F., & Bucci, V. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b04218 · Cited by 5
Self-citationDesign and in situ biosynthesis of precision therapies against gastrointestinal pathogens
Durmusoglu, D., Catella, C. M., Purnell, E. F., Menegatti, S., & Crook, N. (2021) · Current Opinion in Physiology · doi:10.1016/j.cophys.2021.06.007 · Cited by 5
Raeisi, H., Leeflang, J., Hasan, S., & Woods, S. L. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10398-x · Cited by 4
Jin, H., Sun, H., Wang, Q., & Yang, J. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04410-3 · Cited by 3
Metadata
- Authors
- Palmer, J. D., Piattelli, E., McCormick, B. A., Silby, M. W., Brigham, C. J., & Bucci, V.
- Affiliations
- University of Massachusetts Dartmouth (US)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Bucci, Vanni
- Venue
- ACS Infectious Diseases
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-09-20
- Volume
- 4
- Issue
- 1
- Pages
- 39-45
- ISSN
- 2373-8227 (ISSN-L)
- PMC
- PMC5766358
- OpenAlex
- W2755677477
- Cited by
- 133
- References
- 30
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 23 · 2023: 19 · 2022: 19 · 2021: 12 · 2020: 17 · 2019: 6 · 2018: 6
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- ACS Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Division of Biological Infrastructure (1458347)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK056754)
- National Institute of Allergy and Infectious Diseases (R15-AI112985-01A1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- engineered probiotics, Salmonella, tetrathionate, antimicrobial peptides, Escherichia coli, intestinal inflammation, antibiotic resistance, gut dysbiosis, competition assay, anaerobic conditions
- MeSH terms
- Antibiosis, Genetic Engineering, Peptides, Plasmids, Salmonella, Tetrathionic Acid, Probiotics, Gene Order, Antimicrobial Cationic Peptides, Disk Diffusion Antimicrobial Tests
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.